HOME >> BIOLOGY >> NEWS
Team led by Carnegie Mellon University scientist finds first evidence of a living memory trace

An international team of scientists for the first time has detected a memory trace in a living animal after it has encountered a single, new stimulus. The research, done with honeybees sensing new odors, allows neuroscientists to peer within the living brain and explore short-term memory as never before, according to scientist Roberto Fernndez Galn, a leading author on the report who is currently a postdoctoral research associate at Carnegie Mellon University.

Capturing these memory traces could ultimately provide a completely new way to understand how short-term memory works, stated Galn. The findings are scheduled for January publication in Neural Computation.

"Our findings show that an odor produces a memory trace of synchronized neural activity that lasts several minutes after a bee initially senses it," said Galn. "This is the first time anyone has revealed a short-term, stimulus-specific neural pulse within the living brain that occurs after exposure to a previously unknown stimulus."

"Future investigations along the lines of our study may reveal previously overlooked memory traces in many other neural systems," said C. Giovanni Galizia, Galn's primary collaborator, who is now a professor at Konstanz Universitt in Konstanz, Germany.

Galn performed the work as part of his dissertation research while in the research group of Andreas Herz at the Humboldt University in Berlin, Germany.

The report supports Hebb's theory of learning, a 55-year-old proposition that "neurons that fire together wire together," thereby strengthening their connections. According to the theory, a stimulus activates some neurons while inhibiting others. Once this stimulus is removed, traces of that excitation/inhibition pattern so-called Hebbian reverberations should remain.

"We are the first to observe this phenomenon at the network level. We are also the first to detect a distinct signature, not only of a sensory short-term memory, but
'"/>

Contact: Lauren Ward
wardle@andrew.cmu.edu
412-268-7761
Carnegie Mellon University
14-Nov-2005


Page: 1 2 3

Related biology news :

1. Carnegie Mellons Peter Adams receives EPA research grant
2. Carnegie Mellon scientists find key HIV protein makes cell membranes bend more easily
3. Carnegie Mellons David Sholl identifies new materials
4. Carnegie Mellon University scientists identify genes activated during learning and memory
5. Carnegie Mellon University research shows how sensory-deprived brain compensates
6. Carnegie Mellon researchers urge regulators to rethink strategies for soot emission
7. Carnegie Mellon researcher proposes development of artificial cells to fight disease
8. Carnegie Mellon engineers devise new process to improve energy efficiency of ethanol production
9. DNA gets new twist: Carnegie Mellon scientists develop unique DNA nanotags
10. Carnegie Mellons Granger Morgan pens op-ed
11. Carnegie Mellon scientist plays key role in unveiling sea urchin genome

Post Your Comments:
(Date:5/21/2013)... Illinois at Chicago College of Medicine will study gender differences ... main energy source -- and how changes in fat metabolism ... million, 4-year grant from the National Heart, Lung and Blood ... fuel for energy. These changes may play a major role ... men and women, says E. Douglas Lewandowski, director of the ...
(Date:5/21/2013)... few decades, scientists have developed many devices that can ... While generally effective, each of these treatments has drawbacks, ... study from MIT analyzes the potential usefulness of a ... and drug-releasing stents, but may pose fewer risks. With ... artery for only a brief period, during which it ...
(Date:5/21/2013)... 2013 Royal Philips Electronics (NYSE: PHG, AEX: ... portable ultrasound with Philips, industry leading Live 3D TEE, ... xMATRIX with available Live 3D TEE and ICE will ... the EuroPCR, official meeting for the European Association of ... its launch in 2012, Philips CX50 xMATRIX has been ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
(Date:5/21/2013)... -- First patients dosed with PSX1002, an ... using Prosonix, particle engineering platform Prosonix, an ... Respiratory Medicines by Design , has initiated a ... its effect on lung function and the safety of ... severe chronic obstructive pulmonary disease (COPD). The first two ...
(Date:5/21/2013)... by George Washington University Professor Tianshu Li provide ... small droplets is strongly size-dependent, an important conclusion ... formation of ice at the nanoscale is a ... has important implications for climate research and other ... supercooled water is generally initiated by a process ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, innovative ... Genzyme, a Sanofi company and leading biotech company, recently ... a multi-use facility in the United States. With Door ... this latest order underscores the satisfaction and success the ... device improving doorway access control. , “We recommend ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: